<analysis>
**CI-to-horizon mapping (applies to both messages).** CI rises by 1.0 for each roughly 5.6× gain in METR horizon, so a doubling of horizon is about +0.4 CI. Two anchors: 2.9 days sits at about CI-3.99, and CI-4.0 is about 3.0 days. On this scale the internal 3.5-day checkpoint is about CI-4.08, not 4.02, and I will correct this in the world state. DeepSeek V5 at 1.9 days sits about 0.25 CI below the frontier, which is roughly 3–4 months behind rather than "5–7 weeks." I will also correct this.

**Action 1 (held-out test).** Three things must happen in about ten days:
- Blinded authors write 6 more scenarios.
- Engineers are protected from reclaims.
- The cold run completes.

The record on engineer reclaims:
- October and November: harness reclaims happened.
- December: the engineering slot held.
- January: three researchers were pulled, and the serving slot was lost.

The CI-4 evaluations are now live, which makes a reclaim more likely. The board's mid-March deadline gives the chief scientist a real reason to grant protection, but she has not done so before. Whether the detector itself passes is modelled separately under Threat 1.

**Action 2 (methodology package).** This is the third attempt. Recruiting outside the evaluation pool is feasible. Item (c) depends on Action 1. Validating the auditors on checkpoint A competes with the live evaluations. The chief scientist's bar is "complete," and partial approval is the modal outcome. For example, (a) could be approved for the March tranche while (b) is deferred.

**Action 3 (AISI package).** This is routine and within the player's control. Legal review of the log sanitisation may take a few days, but the deadline has slack. AISI's reaction is modelled under Threat 2.

**Action 4 (joint Hawley and earnings handling).** Timely production with a privilege log and consistent 10-K language are standard work for counsel. The risk is internal: securities counsel may still dilute the risk-factor wording. The board's compression pressure on the go/no-go also interacts with the earnings call, where analysts will ask about the release timeline. External escalations are modelled under Threats 3 and 4.

**Action 5 (RAISE).** Adding 800 enrolees in one month is roughly what the last two pushes failed to achieve. Partner academic calendars and a waitlist conversion rate of about 30% limit it. Publishing the Michigan interim is easy. A partial result is likely: the interim is published, and total enrolment lands somewhere around 1,900–2,100.

**Threats**

- **Threat 1.** If the test runs, a detector with n=3 and features tuned on the evaluation set usually degrades on out-of-distribution scenarios. The threat is moot if Action 1 fails.
- **Threat 2.** Scoping the review as "not an assurance" is AISI's default posture, especially after checkpoint access was refused. I cannot confirm the adversary's specific figure of "17 of 19 actions attributed to Mythos 5"; the briefing documents AISI flagging GPT-5.6 Sol. The general caution is plausible either way.
- **Threat 3.** Plaintiff firms routinely announce investigations, but a 6% drop is mild. The step from an investigation to a 10-K rewrite adds further friction.
- **Threat 4.** Production is due on 28 February, so most of any reaction falls in March.
- **Threat 5.** An xAI release outside the review, a Gemini 5.x update, or leaked OpenAI benchmarks are plausible in February. OpenAI's scheduled early-March release is baseline, not this threat. The board's compression pressure is an explicit consequence if this threat materialises. Even if it does not, I will show the effect of mid-March pressure on the interim readout.
</analysis>

<action_odds>
Action 1 [Anomaly held-out test by 10 Feb]: P(failure) 50%. Reason: The live CI-4 evaluations maximise reclaim pressure. Reclaims happened in October, November and January, and the slot held only in December. Six blinded scenarios in ten days is tight. The chief scientist's protection is plausible but has never been granted.

Action 2 [Complete methodology for 17 Feb]: P(failure) 55%. Reason: This is the third attempt against a strict "complete" bar. Item (c) depends on Action 1, and checkpoint-A auditor validation competes with the live evaluations. Partial approval of one or two items is the likeliest success mode.

Action 3 [AISI protocols and logs by 14 Feb]: P(failure) 15%. Reason: This is routine and within the player's control. The only risk is a small delay from legal review of the log sanitisation.

Action 4 [Joint Hawley production and 10-K narrative]: P(failure) 25%. Reason: This is standard work for counsel. The internal risk is that securities counsel dilutes the risk-factor language, and that the pressure to state a release timeline on the earnings call creates inconsistency.

Action 5 [RAISE February intake and Michigan interim]: P(failure) 50%. Reason: Adding 800 in a month repeats a pace that failed twice, and partner calendars constrain it. Publishing the interim is easy, so partial success is likely.
</action_odds>

<threat_odds>
Threat 1 [Detector fails held-out test]: P(materialises) 50%, applying only if Action 1 runs the test (moot otherwise). Adversary suggested 45%; I set it slightly higher because a detector tuned on its own evaluation set with n=3 usually degrades out of distribution. I do not double-count the harness-pull risk, which is already in Action 1's P(failure).

Threat 2 [AISI scopes or conditions the review]: P(materialises) 40%. Adversary suggested 40%; I match it independently. The refusal of checkpoint access makes an "not an assurance" or "we need model access" response AISI's natural posture. I discount the unverified Mythos-specific incident figures, but the general caution stands.

Threat 3 [Plaintiff-firm investigation freezes the narrative]: P(materialises) 25%. Adversary suggested 35%; I set it lower because a 6% drop is modest. Firms do issue investigation releases often, but the full chain (a release, then counsel rewriting the 10-K to boilerplate, then a newsworthy gap) is less likely than the release alone.

Threat 4 [Hawley escalates in February]: P(materialises) 20%. Adversary suggested 30%; I set it lower because production lands on 28 February, which leaves almost no February window. Most of any escalation belongs to March.

Threat 5 [Competitor ships outside the review, or a credible leak]: P(materialises) 25%. Adversary suggested 25%; I match it. xAI's cadence is erratic, a Gemini 5.x update or an OpenAI benchmark leak are each plausible, and V5 has put the industry in race mode. If this materialises, the board's compression of the mid-March go/no-go will be simulated explicitly.
</threat_odds>
